1,3-dipropyl-8-cyclopentylxanthine has been researched along with metoprolol in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baumann, G; Berndt, T; Felix, SB; Frank, TM; Harms, C; Kästner, R; Stangl, V | 1 |
Baumann, G; Buttke, K; Felix, SB; Frank, T; Harms, C; Muss, J; Stangl, K; Stangl, V | 1 |
2 other study(ies) available for 1,3-dipropyl-8-cyclopentylxanthine and metoprolol
Article | Year |
---|---|
Release of a stable cardiodepressant mediator after myocardial ischaemia during reperfusion.
Topics: Adenosine Deaminase; Adrenergic beta-Antagonists; Animals; Autacoids; Catalase; Depression, Chemical; Female; Free Radical Scavengers; Guinea Pigs; Male; Metoprolol; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion; Myocardium; Naphthalenes; Nitric Oxide Synthase; Nitroarginine; Perfusion; Phospholipases A; Purinergic P1 Receptor Antagonists; Purinergic P2 Receptor Antagonists; Pyrones; Superoxide Dismutase; Theobromine; Xanthines | 1997 |
Cardiodepressant mediators are released after myocardial ischaemia: modulation by catecholamines and adenosine.
Topics: Adenosine; Adrenergic beta-Antagonists; Animals; Catecholamines; Chromatography, High Pressure Liquid; Guinea Pigs; In Vitro Techniques; Metoprolol; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion; Myocardium; Purinergic P1 Receptor Antagonists; Purinergic P2 Receptor Antagonists; Theobromine; Ventricular Function, Left; Xanthines | 1999 |